CNS Pharmaceuticals, Inc. (CNSP)
5.21
-0.14
(-2.62%)
USD |
NASDAQ |
Feb 04, 16:00
5.24
+0.03
(+0.58%)
After-Hours: 20:00
CNS Pharmaceuticals EPS Diluted (Quarterly) : -5.759 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
| Oragenics, Inc. | -1.965 |
| NanoViricides, Inc. | -0.1045 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.218M |
| Total Expenses (Quarterly) | 3.218M |
| Enterprise Value | -6.602M |
| Earnings Yield | -781.5% |
| Normalized Earnings Yield | -781.53 |